| |
Adjusted
‡
|
---|
Outcome
| | β* |
p-value
|
---|
IL-13
| | | |
|
Media
| 0.9 | 0.08 |
|
Fel d 1
|
1.56
|
0.007
|
|
Der f 1
|
1.9
|
0.0006
|
|
PHA
|
1.82
|
0.002
|
|
LPS
|
1.38
|
0.01
|
IFN-γ
| | | |
|
Media
|
1.24
|
0.02
|
|
Fel d 1
|
1.23
|
0.01
|
|
Der f 1
| 0.90 | 0.07 |
|
PHA
|
1.27
|
0.03
|
|
LPS
| 0.76 | 0.17 |
IL-10
| | | |
|
Media
| -0.66 | 0.08 |
|
Fel d 1
| -0.51 | 0.42 |
|
Der f 1
| -0.36 | 0.60 |
|
PHA
| -0.11 | 0.88 |
|
LPS
| -0.19 | 0.70 |
- *Change of one log10 pg/ml cytokine level in children born by cesarean section as compared to children born by vaginal delivery.
- ‡Foroutcome IL-13, model adjusted for maternal age, maternal atopy, neonatal birth weight, neonatal gestational age, and neonatal birth length.
- For outcome IFN-γ, model adjusted for maternal age, maternal atopy, and neonatal birth weight.
- For outcome IL-10, model adjusted for maternal age, neonatal gestational age, and neonatal birth weight.